2024
The influence of ovarian hormones on the putative mechanisms that promote female nicotine use
Giner P, Ortegon S, Bagdas D, O'Dell L. The influence of ovarian hormones on the putative mechanisms that promote female nicotine use. Current Opinion In Neurobiology 2024, 88: 102900. PMID: 39153250, PMCID: PMC11560049, DOI: 10.1016/j.conb.2024.102900.Peer-Reviewed Original ResearchNicotine useWithdrawal severityOvarian hormonesImpact of ovarian hormonesNicotine withdrawal severityHormonal interventionsInfluence of ovarian hormonesNovel treatment avenuesHormone-based contraceptivesWithdrawal symptomsPleasurable effectsQuit dateCessation treatmentMenstrual cyclePost-menopausalHormonal fluctuationsTreatment efficacyTreatment avenuesNicotineCessation interventionsCessation strategiesCessation approachesWithdrawalHormoneWomen
2018
New insights on the effects of varenicline on nicotine reward, withdrawal and hyperalgesia in mice
Bagdas D, Alkhlaif Y, Jackson A, Carroll FI, Ditre JW, Damaj MI. New insights on the effects of varenicline on nicotine reward, withdrawal and hyperalgesia in mice. Neuropharmacology 2018, 138: 72-79. PMID: 29860196, PMCID: PMC6054891, DOI: 10.1016/j.neuropharm.2018.05.025.Peer-Reviewed Original ResearchConceptsEffects of vareniclineNicotine withdrawal signsNicotine rewardΑ5 nAChRWithdrawal signsHigh doseKnockout miceΒ2-nAChRsNicotine withdrawal-induced hyperalgesiaAdministration of vareniclineWithdrawal-induced hyperalgesiaΑ7 knockout miceDose-related mannerNicotinic acetylcholine receptorsΑ5 knockout micePlace preference testVarenicline doseCessation treatmentNicotine withdrawalSomatic signsVareniclineΑ7 nAChRsMouse modelCPP testNicotinic subtypes